IO Biotech Files 8-K on Security Holder Vote Matters
Ticker: IOBT · Form: 8-K · Filed: Jun 11, 2024 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
IO Biotech shareholders are voting on key company issues; watch for outcomes.
AI Summary
IO Biotech, Inc. filed an 8-K on June 11, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 6, 2024. The company, incorporated in Delaware with its principal executive offices in Copenhagen, Denmark, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing indicates a significant event where security holders are being asked to vote on important company matters, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: medium — Filings related to security holder votes can signal potential changes in corporate governance or strategic direction, which may carry inherent risks.
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- June 6, 2024 (date) — Date of earliest event reported
- June 11, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Copenhagen, Denmark (location) — Principal Executive Offices
FAQ
What specific matters were submitted for a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 6, 2024.
What is the principal executive office address of IO Biotech, Inc.?
The principal executive offices are located at Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for IO Biotech, Inc.?
The Standard Industrial Classification (SIC) code for IO Biotech, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 535 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-06-11 16:44:30
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share IOBT The Nasdaq Stock Mar
Filing Documents
- d768244d8k.htm (8-K) — 30KB
- 0001193125-24-159193.txt ( ) — 149KB
- iobt-20240606.xsd (EX-101.SCH) — 3KB
- iobt-20240606_lab.xml (EX-101.LAB) — 17KB
- iobt-20240606_pre.xml (EX-101.PRE) — 11KB
- d768244d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. IO Biotech, Inc. Date: June 11, 2024 By: /s/ Mai-Britt Zocca, Ph.D. Mai-Britt Zocca, Ph.D. Chief Executive Officer